GT201000066A - Una vacuna multicomponente o monocomponente, para ser utilizada contra la enfermedad de chagas, composiciones farmaceuticas que las contienen, procedimiento para la obtención del inmunógeno de dichas vacunas y acido nucleico utilizado en dicho proced - Google Patents
Una vacuna multicomponente o monocomponente, para ser utilizada contra la enfermedad de chagas, composiciones farmaceuticas que las contienen, procedimiento para la obtención del inmunógeno de dichas vacunas y acido nucleico utilizado en dicho procedInfo
- Publication number
- GT201000066A GT201000066A GT201000066A GT201000066A GT201000066A GT 201000066 A GT201000066 A GT 201000066A GT 201000066 A GT201000066 A GT 201000066A GT 201000066 A GT201000066 A GT 201000066A GT 201000066 A GT201000066 A GT 201000066A
- Authority
- GT
- Guatemala
- Prior art keywords
- vaccines
- multicomponent
- procedure
- obtaining
- nucleic acid
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 206010001935 American trypanosomiasis Diseases 0.000 title abstract 2
- 208000024699 Chagas disease Diseases 0.000 title abstract 2
- 241000223109 Trypanosoma cruzi Species 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002163 immunogen Effects 0.000 title 1
- 241000223104 Trypanosoma Species 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 244000045947 parasite Species 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 230000007923 virulence factor Effects 0.000 abstract 1
- 239000000304 virulence factor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/005—Trypanosoma antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A UNA VACUNA CONTRA LA ENFERMEDAD DE CHAGAS, CAPAZ DE ESTIMULAR LA RESPUESTA INMUNE CONTRA EL FACTOR DE LA VIRULENCIA TRANS-SIALIDASA DEL PARÁSITO TRYPANOSOMA CRUZI, CARACTERIZADA DICHA VACUNA PORQUE COMPRENDE UNA PORCIÓN INMUNÓGENICA Y POLINUCLEÓTIDOS, TAMBIÉN SE INCLUYE EN LA PRESENTE INVENCIÓN LAS COMPOSICIONES FARMACÉUTICAS QUE CONTIENEN DICHAS VACUNAS MULTICOMPONENTES Y MONOCOMPONENTES, PROCEDIMIENTOS PARA LA OBTENCIÓN DE LA PORCIÓN INMUNOGENA DE DICHAS VACUNAS Y EL ÁCIDO NUCLEICO UTILIZADO EN DICHO PROCEDIMIENTO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP070104827A AR064593A1 (es) | 2007-10-31 | 2007-10-31 | Una vacuna multicomponente o monocomponente para ser utilizada contra la enfermedad de chagas, composiciones farmaceuticas que las contienen, procedimiento para la obtencion del inmunogeno de dichas vacunas y acido nucleico utilizado en dicho procedimiento. |
Publications (1)
Publication Number | Publication Date |
---|---|
GT201000066A true GT201000066A (es) | 2012-04-03 |
Family
ID=40591558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT201000066A GT201000066A (es) | 2007-10-31 | 2010-03-23 | Una vacuna multicomponente o monocomponente, para ser utilizada contra la enfermedad de chagas, composiciones farmaceuticas que las contienen, procedimiento para la obtención del inmunógeno de dichas vacunas y acido nucleico utilizado en dicho proced |
Country Status (18)
Country | Link |
---|---|
US (3) | US8900598B2 (es) |
EP (1) | EP2206513B1 (es) |
AR (1) | AR064593A1 (es) |
BR (1) | BRPI0805753A2 (es) |
CA (1) | CA2702534C (es) |
CO (1) | CO6280407A2 (es) |
CR (1) | CR11334A (es) |
DO (1) | DOP2010000083A (es) |
EC (1) | ECSP10010055A (es) |
ES (1) | ES2569943T3 (es) |
GT (1) | GT201000066A (es) |
HN (1) | HN2010000750A (es) |
MX (1) | MX2010004626A (es) |
NI (1) | NI201000071A (es) |
PA (1) | PA8816401A1 (es) |
PE (2) | PE20091161A1 (es) |
UY (1) | UY31451A1 (es) |
WO (1) | WO2009056965A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR064593A1 (es) * | 2007-10-31 | 2009-04-15 | Baeremaecker Barros Carlos De | Una vacuna multicomponente o monocomponente para ser utilizada contra la enfermedad de chagas, composiciones farmaceuticas que las contienen, procedimiento para la obtencion del inmunogeno de dichas vacunas y acido nucleico utilizado en dicho procedimiento. |
WO2011031317A2 (en) * | 2009-09-10 | 2011-03-17 | The Board Of Regents Of The University Of Texas System | Vaccine for control of trypanosoma cruzi infection and chagas disease |
US9926349B2 (en) * | 2011-07-21 | 2018-03-27 | Consejo Superior De Investigaciones Cientifícas (Csic) | Chimeric molecule useful in immunotherapy for leishmaniasis, which includes a fragment of the PFR1 protein of leishmania infantum with specific immunodominant epitopes |
US9566320B2 (en) | 2013-09-24 | 2017-02-14 | The Board Of Regents Of The University Of Texas System | Mucin-associated surface protein as vaccine against Chagas disease |
US10279023B2 (en) | 2013-09-24 | 2019-05-07 | Board Of Regents, The University Of Texas System | Mucin-associated surface protein as a vaccine against chagas disease |
WO2016209598A1 (en) * | 2015-06-23 | 2016-12-29 | Saint Louis University | Peptides for inducing chagas disease responses |
BR102021010469A2 (pt) * | 2021-05-28 | 2022-12-13 | Fundação Oswaldo Cruz | Proteína quimérica recombinante, seu uso, e, composição |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0586687A4 (en) | 1992-03-25 | 1996-04-17 | Univ New York | Trans-sialidase and methods of use and making thereof |
US6875584B1 (en) * | 1999-03-02 | 2005-04-05 | University Of Georgia Research Foundation, Inc. | Prophylactic and therapeutic immunization against protozoan infection and disease |
US7060676B2 (en) * | 1999-12-20 | 2006-06-13 | Trustees Of Tufts College | T. cruzi-derived neurotrophic agents and methods of use therefor |
US7780969B2 (en) * | 2005-07-15 | 2010-08-24 | University Of Georgia Research Foundation, Inc. | Trypanosoma cruzi proteome compositions and methods |
WO2007107488A2 (en) * | 2006-03-17 | 2007-09-27 | Vib Vzw | Vaccine against trypanosoma cruzi infection |
AR064593A1 (es) * | 2007-10-31 | 2009-04-15 | Baeremaecker Barros Carlos De | Una vacuna multicomponente o monocomponente para ser utilizada contra la enfermedad de chagas, composiciones farmaceuticas que las contienen, procedimiento para la obtencion del inmunogeno de dichas vacunas y acido nucleico utilizado en dicho procedimiento. |
-
2007
- 2007-10-31 AR ARP070104827A patent/AR064593A1/es unknown
-
2008
- 2008-10-30 WO PCT/IB2008/002923 patent/WO2009056965A2/es active Application Filing
- 2008-10-30 MX MX2010004626A patent/MX2010004626A/es active IP Right Grant
- 2008-10-30 PE PE2008001858A patent/PE20091161A1/es not_active Application Discontinuation
- 2008-10-30 US US12/740,393 patent/US8900598B2/en not_active Expired - Fee Related
- 2008-10-30 EP EP08844056.5A patent/EP2206513B1/en not_active Not-in-force
- 2008-10-30 PE PE2013002770A patent/PE20140520A1/es active IP Right Grant
- 2008-10-30 ES ES08844056.5T patent/ES2569943T3/es active Active
- 2008-10-30 CA CA2702534A patent/CA2702534C/en not_active Expired - Fee Related
- 2008-10-31 BR BRPI0805753-2A patent/BRPI0805753A2/pt not_active Application Discontinuation
- 2008-10-31 UY UY31451A patent/UY31451A1/es not_active Application Discontinuation
-
2009
- 2009-02-19 PA PA20098816401A patent/PA8816401A1/es unknown
-
2010
- 2010-03-15 DO DO2010000083A patent/DOP2010000083A/es unknown
- 2010-03-23 GT GT201000066A patent/GT201000066A/es unknown
- 2010-03-24 CR CR11334A patent/CR11334A/es unknown
- 2010-03-26 EC EC2010010055A patent/ECSP10010055A/es unknown
- 2010-04-21 HN HN2010000750A patent/HN2010000750A/es unknown
- 2010-04-26 NI NI201000071A patent/NI201000071A/es unknown
- 2010-05-18 CO CO10058905A patent/CO6280407A2/es unknown
-
2014
- 2014-10-31 US US14/529,454 patent/US9662378B2/en not_active Expired - Fee Related
-
2017
- 2017-04-20 US US15/492,365 patent/US10213500B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CO6280407A2 (es) | 2011-05-20 |
CA2702534C (en) | 2016-10-18 |
US10213500B2 (en) | 2019-02-26 |
US8900598B2 (en) | 2014-12-02 |
AR064593A1 (es) | 2009-04-15 |
US20150056243A1 (en) | 2015-02-26 |
HN2010000750A (es) | 2013-08-19 |
US20170290896A1 (en) | 2017-10-12 |
WO2009056965A2 (es) | 2009-05-07 |
PE20140520A1 (es) | 2014-05-05 |
EP2206513A2 (en) | 2010-07-14 |
US20100297186A1 (en) | 2010-11-25 |
EP2206513B1 (en) | 2016-02-17 |
ES2569943T3 (es) | 2016-05-13 |
DOP2010000083A (es) | 2010-07-15 |
CA2702534A1 (en) | 2009-05-07 |
MX2010004626A (es) | 2010-10-04 |
PA8816401A1 (es) | 2009-09-17 |
PE20091161A1 (es) | 2009-08-28 |
WO2009056965A3 (es) | 2009-07-23 |
NI201000071A (es) | 2010-11-10 |
UY31451A1 (es) | 2009-05-29 |
BRPI0805753A2 (pt) | 2012-04-17 |
CR11334A (es) | 2010-05-26 |
US9662378B2 (en) | 2017-05-30 |
ECSP10010055A (es) | 2010-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT201000066A (es) | Una vacuna multicomponente o monocomponente, para ser utilizada contra la enfermedad de chagas, composiciones farmaceuticas que las contienen, procedimiento para la obtención del inmunógeno de dichas vacunas y acido nucleico utilizado en dicho proced | |
CL2019003264A1 (es) | Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas. (divisional solicitud 201703151) | |
AR088820A1 (es) | Moleculas de anticuerpo que tienen especificidad por ox40 humano | |
PE20151588A1 (es) | Vacuna contra el virus del dengue | |
CR10559A (es) | Vacuna de influenza | |
CO6781540A2 (es) | Protéinas de fusión y vacunas de combinación que comprenden proteína e y pilina a de haemophilus influenzae | |
BR112016010383A2 (pt) | compostos de pyy seletivos e usos dos mesmos | |
BR112015018168A2 (pt) | inibidores de rock suaves | |
BR112013026661A2 (pt) | método de entrega de vacina | |
CL2017001961A1 (es) | Vacuna bivalente contra el virus de gripe porcina | |
CL2015001562A1 (es) | Método para obtener una vacuna de mycoplasma. | |
BR112014001409A2 (pt) | métodos e composições para vacinação contra staphylococcus aureus | |
BR112017008993A2 (pt) | métodos e composições especificamente para o tratamento de transtorno de déficit de atenção | |
AR108829A1 (es) | Vacuna contra virus de bronquitis infecciosa | |
CA2915027A1 (en) | Compositions and methods for administration of vaccines against dengue virus | |
EA201491818A1 (ru) | Способ получения оптически чистых и необязательно замещенных производных 2-(1-гидроксиалкил)хромен-4-она и их применение при получении лекарственных препаратов | |
NZ731659A (en) | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus | |
BR112012016048A2 (pt) | "exossomas derivados de reticulócitos infectados com plasmodium sp., método para obter os mesmos e usos dos mesmos". | |
BR112017022755A2 (pt) | formulações de glucopiranosil lipídeo a e alérgeno a amendoim para administração sublingual | |
BR112015030431A2 (pt) | formulação de liberação modificada | |
EA201690115A1 (ru) | Комбинированные иммуногенные композиции | |
BR112014001039A2 (pt) | parasita vivo pertencente ao gênero plasmodium, composição imunogênica, vacina contra a malária, uso de um parasita e método para imunizar um paciente contra malária | |
BR112015002549A2 (pt) | regime de vacinação para proteger uma criança contra infecção ou doença causada por vírus sincicial respiratório, composição imunogênica ou pluralidade de composições imunogênicas, uso de uma composição imunogênica ou de uma pluralidade de composições imunogênicas | |
BR112014012184A2 (pt) | vacina de malária | |
AR090726A1 (es) | Vacunas y procedimientos para tratar la enfermedad de lyme en perros |